A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

February 17, 2022

Primary Completion Date

December 1, 2026

Study Completion Date

June 30, 2027

Conditions
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Interventions
DRUG

azenosertib

Azenosertib (ZN-c3) will be administered orally.

Trial Locations (70)

168

RECRUITING

Site 3304 - Fondazione Policlinico Universitario A Gemelli, Rome

3021

RECRUITING

Site 2716 - Epworth Healthcare Freemasons, Footscray

4032

RECRUITING

Site 2715 - Icon Cancer Centre - Chermside, Brisbane

4101

RECRUITING

Site 2707 - Mater Brisbane, South Brisbane

5037

RECRUITING

Site 2709 - Icon Cancer Research Adelaide, Adelaide

5065

RECRUITING

Site 2702 - Burnside War Memorial Hospital - The Brian Fricker Oncology Centre, Toorak Gardens

6008

RECRUITING

Site 2717 - St John of God Hospital Subiaco, Subiaco

6009

RECRUITING

Site 2701 - Sir Charles Gairdner Hospital, Nedlands

8035

RECRUITING

Site 3511 - Instituto de Investigacion Oncologica Vall d'Hebron, Barcelona

9300

RECRUITING

Site 3101 - AZORG - Aalst, Aalst

11030

ACTIVE_NOT_RECRUITING

Site 0231 - Northwell Health Cancer Institute, Manhasset

19096

ACTIVE_NOT_RECRUITING

Site 0277 - Alliance Cancer Specialist, PC, Wynnewood

19104

RECRUITING

Site 0232 - University of Pennsylvania, Philadelphia

19107

RECRUITING

Site 0178 - Thomas Jefferson University, Philadelphia

20132

RECRUITING

Site 3307 - Ospedale San Raffaele S.r.l., Milan

20141

RECRUITING

Site 3305 - Istituto Europeo di Oncologia, Milan

20876

RECRUITING

Site 0146 - Maryland Oncology Hematology, PA, Rockville

21079

RECRUITING

Site 3601 - Centre Georges François Leclerc, Dijon

23320

RECRUITING

Site 0295 - Virginia Oncology Associates, Chesapeake

25030

RECRUITING

Site 3613 - Hopital Jean Minjoz, Besançon

27710

RECRUITING

Site 0259 - Duke Cancer Center, Durham

28027

RECRUITING

Site 3517 - Clinica Universidad de Navarra, Madrid

29200

RECRUITING

Site 3617 - CHU de Brest - Hôpital La Cavale Blanche, Brest

31000

RECRUITING

Site 3603 - Institut Claudius Regaud, Toulouse

31404

ACTIVE_NOT_RECRUITING

Site 0236 - Memorial Health, Savannah

32117

RECRUITING

Site 0239 - Florida Cancer Specialists - East, Daytona Beach

32803

RECRUITING

Site 0308 - AdventHealth, Orlando

33140

RECRUITING

Site 0173 - Mount Sinai Medical Center, Miami Beach

36604

RECRUITING

Site 0170-USA Mitchell Cancer Institute, Mobile

37126

RECRUITING

Site 3311 - Azienda Ospedaliera Universitaria Integrata Di Verona, Verona

40202

RECRUITING

Site 0251 - Norton Cancer Institute, Louisville

43026

RECRUITING

Site 0214-Ohio State University Comprehensive Cancer Center, Hilliard

43219

RECRUITING

Site 0243 - Mark H Zangmeister Cancer Center, Columbus

44800

RECRUITING

Site 3614 - Institut de Cancerologie de l'oust, Saint-Herblain

45242

RECRUITING

Site 0147 - Trihealth Cancer Institute - Harold and Eugen, Cincinnati

46250

RECRUITING

Site 0284 - Community Health Network, Indianapolis

46260

RECRUITING

Site 0217 - St Vincent Hospital and Health Care Centers, Indianapolis

48201

RECRUITING

Site 0101 - Barbara Ann Karmanos Cancer Institute, Detroit

49503

RECRUITING

Site 0228 - Corewell Health Medical Group West, Grand Rapids

55109

RECRUITING

Site 0288 - Minnesota Oncology Hematology - Maplewood, Maplewood

57105

RECRUITING

Site 0132 - Avera Cancer Institute, Sioux Falls

59000

RECRUITING

Site 3602 - Centre Oscar Lambret, Lille

65807

ACTIVE_NOT_RECRUITING

Site 0226 - CoxHealth, Springfield

67200

RECRUITING

Site 3611 - ICANS - Institut de cancérologie Strasbourg Europe, Strasbourg

68114

ACTIVE_NOT_RECRUITING

Site 0317 - Nebraska Methodist Hospital, Omaha

69310

RECRUITING

Site 3608 - Hospices Civils de Lyon - Hôpital Lyon Sud, Pierre-Bénite

69373

RECRUITING

Site 3619 - Centre Léon Bérard, Lyon

75181

RECRUITING

Site 3615 - Hôpital Cochin Port-Royal AP-HP, Paris

75702

RECRUITING

Site 0203 - Texas Oncology, Tyler

77030

RECRUITING

Site 0234 - University of Texas Health, Memorial Hermann Hospital, Houston

80218

RECRUITING

Site 0135 - Rocky Mountain Cancer Centers, Lone Tree

85016

RECRUITING

Site 0143 - HonorHealth, Phoenix

85724

RECRUITING

Site 0102 - University of Arizona Cancer Center, Tucson

89511

RECRUITING

Site 0213 - Center of Hope, Reno

92037

RECRUITING

Site 0258 - UC San Diego Moores Cancer Center, La Jolla

93105

RECRUITING

Site 0287 - Ridley Tree Cancer Center, Santa Barbara

94800

RECRUITING

Site 3604 - Institut Gustave Roussy, Villejuif

97401

RECRUITING

Site 0316 - Oncology Associates of Oregon, P.C., Eugene

98684

RECRUITING

Site 0323 - Compass Oncology, Vancouver

06106

RECRUITING

Site 0158 - Hartford HealthCare, Hartford

02111

RECRUITING

Site 0221 - Tufts Medical Center - PPDS, Boston

02215

RECRUITING

Site 0104 - Dana Farber Cancer Institute, Boston

01805

RECRUITING

Site 0307 - Lahey Hospital and Medical Center, Burlington

01199

RECRUITING

Site 0263 - Baystate Medical Center, Springfield

06100

RECRUITING

Site 3616 - Centre Antoine Lacassagne, Nice

60-693

RECRUITING

Site 2414 - Med-Polonia Sp. z o.o., Poznan

30-348

RECRUITING

Site 2405 - Centrum Badan Klinicznych JCI, Krakow

02-781

RECRUITING

Site 2404 - Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie, Warsaw

15-027

RECRUITING

Site 2419 - Bialostockie Centrum Onkologii im. Marii Sklodowskiej-Curie w Bialymstoku, Bialystok

81-519

RECRUITING

Site 2421 - Szpitale Pomorskie Sp. z o. o., Gdynia

All Listed Sponsors
lead

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

INDUSTRY

NCT05128825 - A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter